ERAPs Reduce In Vitro HIV Infection by Activating Innate Immune Response

Recombinant human (rh) ERAP2-treated PBMCs are less susceptible to in vitro HIV-1 infection even when CD8(+) T cells are depleted. We therefore investigated whether ERAP2 can trigger other immunocompetent cells, boosting their antiviral potential. To this end, human monocyte-derived macrophages (MDM...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunol
Main Authors: Saulle, Irma, Marventano, Ivana, Saresella, Marina, Vanetti, Claudia, Garziano, Micaela, Fenizia, Claudio, Trabattoni, Daria, Clerici, Mario, Biasin, Mara
Formato: Artigo
Idioma:Inglês
Publicado: AAI 2021
Assuntos:
Innate Immunity and Inflammation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7980528/
https://ncbi.nlm.nih.gov/pubmed/33619214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2000991
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares